Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. - Wikidata - awgldk - TriplyDB

Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.

Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.

http://www.wikidata.org/entity/Q37341103

about

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?Clinical adoption of prognostic biomarkers: the case for heart failure Neuregulin as a heart failure therapy and mediator of reverse remodeling Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease Relationship between clinical data and gene expression in the HER2/ErbB2-dependent signaling pathway in patients with acute heart failure.Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure.Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future Directions Common variants in HSPB7 and FRMD4B associated with advanced heart failure Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes.Canonical correlation analysis for gene-based pleiotropy discovery Platelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function.Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.Neuregulin-1β for the treatment of systolic heart failure.Associations of Sleep Apnea, NRG1 Polymorphisms, Alcohol Consumption, and Cerebral White Matter Hyperintensities: Analysis with Genome-Wide Association Data.The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia.Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth.Multiple biomarkers for risk prediction in chronic heart failure.Non-iterative, regression-based estimation of haplotype associations with censored survival outcomes.Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics.Diagnostic Utility of Neuregulin for Acute Coronary Syndrome.Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure Neuregulin in cardiovascular development and disease Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats.Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure.Strain improves risk prediction beyond ejection fraction in chronic systolic heart failure.Signalling between microvascular endothelium and cardiomyocytes through neuregulin.Novel biomarkers in chronic heart failure.Therapeutic implications of biomarkers in chronic heart failure.Emerging paradigms in cardiomyopathies associated with cancer therapies.The roles of neuregulin-1 in cardiac development, homeostasis, and disease.Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts.Improving prediction of cardiovascular complications of cancer therapy: what does the future hold?

P2860

Q24610732-10F5CA1C-2797-4D47-BE0F-E233AC05B0E0 Q24625036-33C198CC-9E8C-4867-A7C4-8EE31D89D5D3 Q26740352-A0BC3C37-A4EC-4240-A2E5-D995CF7E8775 Q26863716-2A5E6A7A-CEDA-4B65-9358-436AD17ECD23 Q26991903-D3053B24-9B30-422A-9E00-4AFB88984130 Q27010136-C0162F8B-A6A4-4EAB-BECF-730A834D1412 Q30663382-63A0B105-71C4-4DC6-A52F-F02B6311CC1B Q33526958-58824A5F-130E-44B7-B149-19B7461D4AB1 Q33907581-D9498A31-A23B-4FA7-B12C-528368E36560 Q34096292-5FE87486-89AA-4055-A461-5D99FF3FDA89 Q34336054-7FF455D4-BDD8-43C9-ADAD-AF46622FD162 Q34350835-CD946B3B-73C2-426A-A610-265EE80CD3E5 Q35088053-14B8D7A8-B81E-470D-B48C-95519F53111A Q35207833-929F6FC8-6969-41F7-8EEF-A43C7618A3EF Q35231868-7BEABE9A-9E46-4D3E-85B0-AE6A86723EBC Q35343873-DE9AFBBC-45D5-4D25-86D9-A1EB68E4B8E1 Q35354723-AEAB5742-EE98-4F54-81FA-7B4B74E922ED Q35552999-1FFFE512-E436-4DE3-919A-B9899A759968 Q36016681-D2F18C80-20F4-45C5-8BAB-92ED64D87FFA Q36070049-F8668E96-AE57-4015-8111-1C474D7086E9 Q36090710-2407E0C2-B9C8-439B-A06E-B3DA49A6E379 Q36311874-2DBB3329-D21B-47FE-BEF5-48FE806AA486 Q36582822-F9E4798F-E6C9-4013-881B-085A1311A35E Q36630478-78C0EB9F-B562-41FC-BB67-38E0935739EE Q36773401-9C650B20-BDCF-455F-86AB-DB19A3DD37EC Q36887091-A2676204-0872-4663-BBEB-A7146C2DA5DA Q36891574-9ACD04C1-8000-4C5E-BF63-B4385B86BA9C Q37029837-7382A5D5-8289-4238-8C3B-2A23959F9411 Q37118330-F447C682-419B-4131-B4F4-9AEB75D531C6 Q37288691-4A4F9BEE-5EC0-45F6-A699-51E8628A1380 Q37619124-07AAA631-A64F-4D45-A1F0-6DAF06AE4F54 Q37648419-39F13807-CAE6-449E-B0EE-5BB4451C19F5 Q37707158-55DE94E4-AB44-42E7-8611-1D436CF18AFB Q37997237-FA0D3063-DF1A-46C3-86E7-CD64BCC109CA Q38121720-525B62DC-035B-475A-B812-D63C617CC9E9 Q38132645-367C7561-F73E-4B23-BBED-C89DE7CFDECC Q38448410-7E8C3757-0078-4FC9-B672-9DDB3E387EAF Q38500442-C9BD4360-4782-4A96-A04A-3F9710B9FDE6 Q38713492-CEA0FD98-3E02-476D-AE9A-A120DF552E85 Q38978030-4E2DB6BB-5618-47DB-A22C-375158BCDB0F

P2860

Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.

http://www.wikidata.org/entity/Q37341103

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuregulin-1 beta is associate ...... omes in chronic heart failure.

@en

Neuregulin-1 beta is associate ...... omes in chronic heart failure.

@nl

type

label

Neuregulin-1 beta is associate ...... omes in chronic heart failure.

@en

Neuregulin-1 beta is associate ...... omes in chronic heart failure.

@nl

prefLabel

Neuregulin-1 beta is associate ...... omes in chronic heart failure.

@en

Neuregulin-1 beta is associate ...... omes in chronic heart failure.

@nl

P1433

Q37341103-4E839FC3-A72C-45C5-B13B-5F0665B51F42

P1476

Q37341103-8823EA97-1C00-48B2-BD9B-349641AF957A

P2093

Q37341103-2DB64663-826B-47B4-AA85-3151CC3F8E0F

Q37341103-3BCF91E2-84DA-4FF7-97B2-2CFA56209D63

Q37341103-7897C226-D138-4D2C-B82B-590640C1C636

Q37341103-8AE197E6-FCEC-4A40-98A5-5A28F2DD59E7

Q37341103-DDAA6A88-2022-4333-98B7-FAD3360526C4

Q37341103-E29A82A4-6A6D-4834-98FE-F05F56A38736

Q37341103-F4E462EE-6694-4B64-941B-9E1B2E97B19E

P2860

Q37341103-06BFE5D3-B24D-4863-A8CE-61C1299917CD

Q37341103-0CCCE8EF-E091-4487-AC21-18DBA9A2DF91

Q37341103-15AAC0D1-F801-4442-9733-112A62CF9766

Q37341103-15E8FAA8-3786-4BBB-99E8-9845CA69BA2A

Q37341103-17F21817-48EE-49A3-A945-B27A71ACDEA6

Q37341103-1B2D888E-A3A7-4F98-81A7-6C2CE9FFEC35

Q37341103-22704C97-2F06-4794-AB77-B8C41A3FD83F

Q37341103-26424E1D-6378-47B5-8CF9-1C11E14F79AA

Q37341103-3BCBC822-9912-4CE6-9408-2CDF64AB1CB4

Q37341103-3E7E41F3-284B-48C2-B6FC-8DF76CDC13C4

P304

Q37341103-CABDB8EA-B1AE-45C4-8C00-C1055EBDB202

P31

Q37341103-A4E21819-D88D-46ED-B5DF-BF049551CB6B

P356

Q37341103-D8566219-0AD2-490C-B6AC-5F152C92B566

P407

Q37341103-516A87B7-3D26-4D70-BC11-08244A406C9D

P433

Q37341103-C5ACA846-CF63-4270-892E-6A4CD25C644A

P478

Q37341103-A12A919C-7B01-4564-BDAA-4B20E169358B

P50

Q37341103-C2F6FBA0-127C-4617-9BFE-FD0035FB8BCA

P577

Q37341103-30552794-D3E9-4F01-B093-199B1CA728FB

P698

Q37341103-47506FE4-E7F5-47DB-A3F8-B427A3181CD4

P921

Q37341103-764F678C-B7D3-4888-A3A5-EACDA63433EA

P932

Q37341103-B7A5CEA7-DE25-4A85-9271-978C67D5CBC7

P356

CIRCULATIONAHA.109.856310

P1433

P1476

Neuregulin-1 beta is associate ...... comes in chronic heart failure

@en

P2093

Bonnie Ky

http://www.w3.org/2001/XMLSchema#string

Douglas B Sawyer

http://www.w3.org/2001/XMLSchema#string

James C Fang

http://www.w3.org/2001/XMLSchema#string

Mary E Putt

http://www.w3.org/2001/XMLSchema#string

Radwan N Safa

http://www.w3.org/2001/XMLSchema#string

Stephen E Kimmel

http://www.w3.org/2001/XMLSchema#string

Thomas P Cappola

http://www.w3.org/2001/XMLSchema#string

P2860

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease

Biomarkers in heart failure

Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling

Multiple essential functions of neuregulin in development

Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Signaling pathways for cardiac hypertrophy and failure.

P304

310-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.856310

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19597049

http://www.w3.org/2001/XMLSchema#string

P921

P932

2741393

http://www.w3.org/2001/XMLSchema#string